Publication: Acetaminophen-Induced Liver Injury Alters the Acyl Ethanolamine-Based Anti-Inflammatory Signaling System in Liver.
dc.contributor.author | Rivera, Patricia | |
dc.contributor.author | Pastor, Antoni | |
dc.contributor.author | Arrabal, Sergio | |
dc.contributor.author | Decara, Juan | |
dc.contributor.author | Vargas, Antonio | |
dc.contributor.author | Sanchez-Marin, Laura | |
dc.contributor.author | Pavon, Francisco J | |
dc.contributor.author | Serrano, Antonia | |
dc.contributor.author | Bautista, Dolores | |
dc.contributor.author | Boronat, Anna | |
dc.contributor.author | de-la-Torre, Rafael | |
dc.contributor.author | Baixeras, Elena | |
dc.contributor.author | Lucena, M Isabel | |
dc.contributor.author | de-Fonseca, Fernando R | |
dc.contributor.author | Suarez, Juan | |
dc.contributor.funder | Instituto de Salud Carlos III (ISCIII) | |
dc.contributor.funder | Ministerio de Economía y Competitividad (MINECO) c | |
dc.contributor.funder | Ministerio de Sanidad, Servicios Sociales e Igualdad and Plan Nacional sobre Drogas | |
dc.contributor.funder | Consejería de Economía, Innovación y Ciencia, Junta de Andalucía, UE-ERDF | |
dc.contributor.funder | Consejería de Salud, Junta de Andalucía | |
dc.date.accessioned | 2023-01-25T10:01:03Z | |
dc.date.available | 2023-01-25T10:01:03Z | |
dc.date.issued | 2017-10-06 | |
dc.description.abstract | Protective mechanisms against drug-induced liver injury are actively being searched to identify new therapeutic targets. Among them, the anti-inflammatory N-acyl ethanolamide (NAE)-peroxisome proliferators activated receptor alpha (PPARα) system has gained much interest after the identification of its protective role in steatohepatitis and liver fibrosis. An overdose of paracetamol (APAP), a commonly used analgesic/antipyretic drug, causes hepatotoxicity, and it is being used as a liver model. In the present study, we have analyzed the impact of APAP on the liver NAE-PPARα system. A dose-response (0.5-5-10-20 mM) and time-course (2-6-24 h) study in human HepG2 cells showed a biphasic response, with a decreased PPARα expression after 6-h APAP incubation followed by a generalized increase of NAE-PPARα system-related components (PPARα, NAPE-PLD, and FAAH), including the NAEs oleoyl ethanolamide (OEA) and docosahexaenoyl ethanolamide, after a 24-h exposure to APAP. These results were partially confirmed in a time-course study of mice exposed to an acute dose of APAP (750 mg/kg). The gene expression levels of Pparα and Faah were decreased after 6 h of treatment and, after 24 h, the gene expression levels of Nape-pld and Faah, as well as the liver levels of OEA and palmitoyl ethanolamide, were increased. Repeated APAP administration (750 mg/kg/day) up to 4 days also decreased the expression levels of PPARα and FAAH, and increased the liver levels of NAEs. A resting period of 15 days completely restored these impairments. Liver immunohistochemistry in a well-characterized human case of APAP hepatotoxicity confirmed PPARα and FAAH decrements. Histopathological and hepatic damage (Cyp2e1, Caspase3, αSma, Tnfα, and Mcp1)-related alterations observed after repeated APAP administration were aggravated in the liver of Pparα-deficient mice. Our results demonstrate that the anti-inflammatory NAE-PPARα signaling system is implicated in liver toxicity after exposure to APAP overdose, and may contribute to its recovery through a long-term time-dependent response. | |
dc.description.sponsorship | This work was supported by Instituto de Salud Carlos III (ISCIII), Ministerio de Economía y Competitividad (MINECO) co-funded by UE-ERDF program (JS: PI16/01374; FdF: PI16/01698 and RD16/0017/0001); Ministerio de Sanidad, Servicios Sociales e Igualdad and Plan Nacional sobre Drogas (JS: PNSD2015/047); Consejería de Economía, Innovación y Ciencia, Junta de Andalucía, UE-ERDF (FdF: CTS-8221); Consejería de Salud, Junta de Andalucía, UE-ERDF (FdF: SAS111224; PR: PI-0337-2012); and DIUE, Generalitat de Catalunya (RdT: 2014 SGR 680). FP (CP14/00212), AS (CP14/00173), and JS (CP12/03109) are recipients of a research contract from “Miguel Servet” Program of ISCIII and EU-ERDF. PR holds a “Sara Borrel” research contract from the National System of Health, ISCIII (CD16/00067). | |
dc.description.version | Si | |
dc.identifier.citation | Rivera P, Pastor A, Arrabal S, Decara J, Vargas A, Sánchez-Marín L, et al. Acetaminophen-Induced Liver Injury Alters the Acyl Ethanolamine-Based Anti-Inflammatory Signaling System in Liver. Front Pharmacol. 2017 Oct 6;8:705 | |
dc.identifier.doi | 10.3389/fphar.2017.00705 | |
dc.identifier.issn | 1663-9812 | |
dc.identifier.pmc | PMC5635604 | |
dc.identifier.pmid | 29056914 | |
dc.identifier.pubmedURL | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635604/pdf | |
dc.identifier.unpaywallURL | https://www.frontiersin.org/articles/10.3389/fphar.2017.00705/pdf | |
dc.identifier.uri | http://hdl.handle.net/10668/11713 | |
dc.journal.title | Frontiers in pharmacology | |
dc.journal.titleabbreviation | Front Pharmacol | |
dc.language.iso | en | |
dc.organization | Instituto de Investigación Biomédica de Málaga-IBIMA | |
dc.organization | Hospital Universitario Virgen de la Victoria | |
dc.organization | Hospital Universitario Regional de Málaga | |
dc.page.number | 16 | |
dc.provenance | Realizada la curación de contenido 20/02/2025 | |
dc.publisher | Frontiers Research Foundation | |
dc.pubmedtype | Journal Article | |
dc.relation.projectID | PI16/01374 | |
dc.relation.projectID | RD16/0017/0001 | |
dc.relation.projectID | PNSD2015/047 | |
dc.relation.projectID | CTS-8221 | |
dc.relation.projectID | SAS111224 | |
dc.relation.publisherversion | https://doi.org/10.3389/fphar.2017.00705 | |
dc.rights | Attribution 4.0 International | |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject | FAAH | |
dc.subject | OEA | |
dc.subject | PPARα | |
dc.subject | Hepatic injury | |
dc.subject | Paracetamol | |
dc.subject | Toxicity | |
dc.subject.decs | Acetaminofén | |
dc.subject.decs | Receptores activados del proliferador del peroxisoma | |
dc.subject.decs | Hígado | |
dc.subject.decs | Expresión génica | |
dc.subject.decs | Dosificación | |
dc.subject.decs | Cirrosis hepática | |
dc.subject.mesh | Peroxisome Proliferators | |
dc.subject.mesh | Antipyretics | |
dc.subject.mesh | PPAR alpha | |
dc.subject.mesh | Cytochrome P-450 CYP2E1 | |
dc.subject.mesh | Hep G2 Cells | |
dc.subject.mesh | Immunohistochemistry | |
dc.subject.mesh | Liver Diseases | |
dc.title | Acetaminophen-Induced Liver Injury Alters the Acyl Ethanolamine-Based Anti-Inflammatory Signaling System in Liver. | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 8 | |
dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1